Prevalence of Psychiatric Disorders in the Refugee Population of Turkey

Sponsor
Kutahya Health Sciences University (Other)
Overall Status
Withdrawn
CT.gov ID
NCT05087472
Collaborator
(none)
0
1

Study Details

Study Description

Brief Summary

The investigators are planning to diagnose psychiatric disorders in willing participants from the refugee population in Turkey.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    0 participants
    Observational Model:
    Ecologic or Community
    Time Perspective:
    Cross-Sectional
    Official Title:
    Prevalence of Psychiatric Disorders in the Refugee Population of Turkey
    Actual Study Start Date :
    Dec 9, 2021
    Actual Primary Completion Date :
    Dec 9, 2021
    Actual Study Completion Date :
    Dec 9, 2021

    Outcome Measures

    Primary Outcome Measures

    1. Any diagnosed psychiatric disorder using the Mini-International Neuropsychiatric Interview [Through study completion, on average five months]

      The Mini-International Neuropsychiatric Interview (M.I.N.I.) is a short structured diagnostic interview designed to screen for DSM-5 and ICD-10 psychiatric disorders. It will be utilized on willing participants from Turkey's refugee population.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Having official refugee status in Turkey, willing to participate in the study
    Exclusion Criteria:
    • Having any disability that prevents answering interviewers' questions

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Kütahya Health Sciences University Kütahya Turkey 43100

    Sponsors and Collaborators

    • Kutahya Health Sciences University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Suleyman Keles, MD, Psychiatrist, Head of Community Psychiatry Department, Kutahya Health Sciences University
    ClinicalTrials.gov Identifier:
    NCT05087472
    Other Study ID Numbers:
    • 1
    First Posted:
    Oct 21, 2021
    Last Update Posted:
    Dec 13, 2021
    Last Verified:
    Dec 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 13, 2021